Zhejiang Hisoar Pharmaceutical Co.,Ltd. Posted 39.5 Million Yuan Net Loss in First Three Quarters of 2023

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net loss of 39.5 million yuan in the first three quarters of 2023, reversing a net profit of 205.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 19% year-on-year.

At the end of the reporting period, it had 8.5 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 29.6%.